当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3232770
自主品牌
已选条件
-
T77406lorvotuzumab；洛沃妥珠单抗lorvotuzumab
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1). Lorvotuzumab can be used to synthesize antibody-drug conjugate (Lorvotuzumab mertansine).
价 格：￥电议型 号：T77406产 地：中国大陆
-
T77405Enfortumab；恩诺单抗Enfortumab
Enfortumab is a monoclonal antibody against Nectin-4.Enfortumab can be used to synthesize antibody-drug couplings (enfortumab vedotin) and can also be used in conjunction with platinum compounds to study uroepithelial cancers.
价 格：￥电议型 号：T77405产 地：中国大陆
-
T77404Tesnatilimab；特拉佐利单抗IPH-23XX|||JNJ-64304500|||JNJ 4500；IPH-23XX|||JNJ-64304500|||JNJ 4500
Tesnatilimab is a potent humanized IgG4 monoclonal antibody that binds to the immune-activating receptor NKG2D. Tesnatilimab has potential immunomodulatory and anti-inflammatory activity and can be used to study active ulcerative colitis.
价 格：￥电议型 号：T77404产 地：中国大陆
-
T77401Bavituximab；巴维昔单抗Anti-PS MAb 3G4；Anti-PS MAb 3G4
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a monoclonal antibody against phosphatidylserine (PS) with vascular targeting and immunomodulatory properties. It can reactivate anti-tumor immunity to inhibit tumor growth. Bavituximab has anti-cancer activity and is often used in combination with Paclitaxel and Carboplatin to study non-small cell lung cancer.
价 格：￥电议型 号：T77401产 地：中国大陆
-
T77399Crizanlizumab克立利珠单抗ADAKVEO|||SEG-101
Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease.
价 格：￥电议型 号：T77399产 地：中国大陆
-
T77392Pepinemab；派比奈单抗VX 15/2503；VX 15/2503
Pepinemab(VX 15/2503) is a humanized IgG4 monoclonal antibody targeting sematone 4D. Pepinemab has anti-cancer activity and blocks the activity of SEMA4D, which is used to study degenerative diseases similar to Alzheimer´s disease.
价 格：￥电议型 号：T77392产 地：中国大陆
-
T77385Idactamab；Idactamab单抗INT-001；INT-001
Idactamab (INT-001) is a monoclonal antibody to the human amino acid transport protein ASCT2.
价 格：￥电议型 号：T77385产 地：中国大陆
-
T77379Bexmarilimab；贝马瑞利单抗FP-1305；FP-1305
Bexmarilimab (FP-1305) is a highly potent humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM. Bexmarilimab promotes immune conversion of tumor-associated macrophage phenotype M2 to M1. Bexmarilimab can be used to study cancer.
价 格：￥电议型 号：T77379产 地：中国大陆
-
T77374Ontuxizumab；昂妥昔珠单抗MORAb-004；MORAb-004
Ontuxizumab (MORAb-004) is a monoclonal antibody targeting endomelanic acid with anti-tumor effects.Ontuxizumab is a potent IgG1/κ anti-endothelin (TEM-1 or CD248) monoclonal antibody for the treatment of metastatic melanoma.
价 格：￥电议型 号：T77374产 地：中国大陆
-
T77373Concizumab；康赛珠单抗mAb 2021|||NN 7415；mAb 2021|||NN 7415
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, thereby blocking the interaction of this domain with the FXa active site. Injections of Concizumab increase thrombin in the blood and can be used to prevent and treat hemophilia.
价 格：￥电议型 号：T77373产 地：中国大陆
-
T77372Tisotumab；替索妥单抗1E10|||1.00E+10；1E10|||1.00E+10
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody against tissue factor (TF). Tisotumab is involved in antibody-conjugating drugs that can be used to study cancer.
价 格：￥电议型 号：T77372产 地：中国大陆
-
T77370Ianalumab；伊利尤单抗VAY-736；VAY-736
Ianalumab (VAY-736) is a decarboxylated humanized antibody against BAFF-R. Ianalumab can inhibit the interaction between BAFF and BAFF-R and inhibit the protection of apoptosis mediated by BAFF. Ianalumab has antibody dependent cytotoxicity (ADCC) and works by activating effector cells mediated by the immune receptor tyrosine activation motif (ITAM).
价 格：￥电议型 号：T77370产 地：中国大陆
-
T77369Telazorlimab；特拉佐利单抗ISB-830|||GBR-830；ISB-830|||GBR-830
Telazorlimab (GBR-830) is a humanized monoclonal antibody that targets the OX40 co-stimulatory receptor on activated T cells. Telazorlimab can be used to treat lupus erythematosus and atopic dermatitis.
价 格：￥电议型 号：T77369产 地：中国大陆
-
T77367Urelumab；乌瑞芦单抗BMS-663513|||BMS-66513；BMS-663513|||BMS-66513
Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.Urelumab has potential antitumor activity, potentiating tumor cell killing by T-cells and natural killer cells, and enhancing the cytotoxicity of Rituximab.Urelumab has been used in the study of solid tumor-related diseases such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Urelumab can be used to study diseases associated with solid tumors such as diffuse large B-cell lymphoma (DL
价 格：￥电议型 号：T77367产 地：中国大陆
-
T77364Sibeprenlimab；Sibeprenlimab单抗VIS649|||VIS-649；VIS649|||VIS-649
Sibeprenlimab (VIS649) is a humanized IgG 2 monoclonal antibody that suppresses APRIL. Sibeprenlimab has an inhibitory effect on APRIL and may be studied for the prevention and treatment of kidney disease (IgAN).
价 格：￥电议型 号：T77364产 地：中国大陆
-
T77362Vorsetuzumab；沃瑟妥珠单抗SGN-70；SGN-70
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a monoclonal antibody targeting the CD70 antibody. Vorsetuzumab has anticancer activity and can enhance the macrophage-associated phagocytosis of kidney cancer cells and inhibit Burkitt lymphoma.
价 格：￥电议型 号：T77362产 地：中国大陆
-
T77359Tezepelumab；替西伐单抗Tezepelumab-ekko|||MEDI 19929|||AMG 157；Tezepelumab-ekko|||MEDI 19929|||AMG 157
Tezepelumab (AMG 157) is a humanized monoclonal antibody (IgG2λ) targeting TSLP that prevents TSLP from interacting with its heterodimer receptor. Tezepelumab can be used to study advanced asthma disease.
价 格：￥电议型 号：T77359产 地：中国大陆
-
T77191Clivatuzumab；克利妥珠单抗Clivatuzumab
Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.
价 格：￥电议型 号：T77191产 地：中国大陆
-
T77190Crovalimab；化合物 CrovalimabCrovalimab
Crovalimab (SKY59; RO7112689) is a novel humanized antibody designed to target C5 in a pH-dependent manner, demonstrating binding affinities (KD) of 15.2 nM and 16.8 μM at pH levels of 7.4 and 5.8, respectively. Additionally, it shows high affinity for human FcRn at pH 6.0, with a KD of 17 μM. By blocking C5 cleavage by C5 convertase and inhibiting the activity of a C5 variant (p.Arg885His), Crovalimab effectively prevents the formation of C5b-9 across the classical (CP), lectin (LP), and altern
价 格：￥电议型 号：T77190产 地：中国大陆
-
T77189Sudubrilimab；化合物 SudubrilimabSudubrilimab
Sudubrilimab (HS636), an Ig G1-kappa monoclonal antibody targeting PDL1, is engineered with a TGF-β1 receptor II ectodomain (TGFBR2-ECD) fused to its C-terminus. This design enables Sudubrilimab to simultaneously inhibit the PD-1/PD-L1 pathway and TGF-β bioactivity within the immunosuppressive tumor microenvironment [1].
价 格：￥电议型 号：T77189产 地：中国大陆
